Distribution and determinants of serum high-sensitivity C-reactive protein in Ethiopian population.


Journal

Clinica chimica acta; international journal of clinical chemistry
ISSN: 1873-3492
Titre abrégé: Clin Chim Acta
Pays: Netherlands
ID NLM: 1302422

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 07 07 2020
revised: 01 02 2021
accepted: 10 02 2021
pubmed: 7 3 2021
medline: 22 6 2021
entrez: 6 3 2021
Statut: ppublish

Résumé

C-reactive protein (CRP) is an important inflammatory marker associated with different disease conditions, and its concentration differs among ethnicity. This study aimed to determine the distribution and determinants of serum high-sensitive method CRP (hsCRP) that can measure the typically low concentrations, among the Ethiopian population, for which there is no data. A cross-sectional community-based study was conducted in April-June 2015. A total of 5162 individuals aged 15-69 were included. Behavioral, physical, and biochemical measurements were taken using the WHO STEPS non-communicable diseases (NCDs) risk factors assessment tool. Serum hsCRP was determined using Cobas Integra 400 Plus (Roche). Factors associated with hsCRP levels were also considered. median hsCRP was 0.80 mg/L (Interquartile range, 0.19-2.12) (males: 0.91 mg/L, females: 0.74 mg/L). More than 18% of the study participants had hsCRP greater than 3 mg/L according to the American Heart Association and Centers for Diseases Control and Preventions cut off value. Higher BMI, living in Somali and in Dire Dawa region, and not consuming of fruit or vegetables were independent risk factors for high hsCRP levels. Serum hsCRP levels distribution is comparable to other studies. Until now, no data have been reported in the literature about the Ethiopian population.

Sections du résumé

BACKGROUND BACKGROUND
C-reactive protein (CRP) is an important inflammatory marker associated with different disease conditions, and its concentration differs among ethnicity. This study aimed to determine the distribution and determinants of serum high-sensitive method CRP (hsCRP) that can measure the typically low concentrations, among the Ethiopian population, for which there is no data.
METHODS METHODS
A cross-sectional community-based study was conducted in April-June 2015. A total of 5162 individuals aged 15-69 were included. Behavioral, physical, and biochemical measurements were taken using the WHO STEPS non-communicable diseases (NCDs) risk factors assessment tool. Serum hsCRP was determined using Cobas Integra 400 Plus (Roche). Factors associated with hsCRP levels were also considered.
RESULTS RESULTS
median hsCRP was 0.80 mg/L (Interquartile range, 0.19-2.12) (males: 0.91 mg/L, females: 0.74 mg/L). More than 18% of the study participants had hsCRP greater than 3 mg/L according to the American Heart Association and Centers for Diseases Control and Preventions cut off value. Higher BMI, living in Somali and in Dire Dawa region, and not consuming of fruit or vegetables were independent risk factors for high hsCRP levels.
CONCLUSION CONCLUSIONS
Serum hsCRP levels distribution is comparable to other studies. Until now, no data have been reported in the literature about the Ethiopian population.

Identifiants

pubmed: 33675768
pii: S0009-8981(21)00054-1
doi: 10.1016/j.cca.2021.02.013
pii:
doi:

Substances chimiques

Biomarkers 0
C-Reactive Protein 9007-41-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

99-107

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Auteurs

Feyissa Challa (F)

National Reference Laboratory for Clinical Chemistry, Ethiopian Public Health Institute, Addis Ababa, Ethiopia. Electronic address: Feyissawaka@gmail.com.

Terefe Gelibo (T)

ICAP-Columbia University, Addis Ababa, Ethiopia.

Tigist Getahun (T)

National Reference Laboratory for Clinical Chemistry, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Meron Sileshi (M)

National Reference Laboratory for Clinical Chemistry, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Zeleke Geto (Z)

Department of Biomedical Science, College of Medicine and Health Science, Wollo University, Wollo, Dessie, Ethiopia.

Abebe Bekele (A)

Health System & Reproductive Health Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Theodros Getachew (T)

Health System & Reproductive Health Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Atkure Defar (A)

Health System & Reproductive Health Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Habtamu Teklie (H)

Health System & Reproductive Health Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Bikila Nagasa (B)

National Reference Laboratory for Clinical Chemistry, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Fisume Girma (F)

National Reference Laboratory for Immuno-Hematology, TB/HIV Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Daniel Seifu (D)

Division of Biomedical Sciences, University of Global Health Equity, Kigali, Rwanda. Electronic address: dseifu@ughe.org.

Solomon Tebeje (S)

Department of Biochemistry, College of Health Science, Addis Ababa University, Addis Ababa, Ethiopia.

Solomon Teferra (S)

Department of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Mistire Wolde (M)

Department of Medical Laboratory Sciences, College of Health Science, Addis Ababa University, Addis Ababa, Ethiopia.

Anna Carobene (A)

Laboratory Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: carobene.anna@hsr.it.

Ebba Abate (E)

National Reference Laboratory for Clinical Chemistry, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH